HIV-1 Vpr enhances production of receptor of activated NF-κB ligand (RANKL) via potentiation of glucocorticoid receptor activity

Archives of Virology

Volumn 150, Issue 1, 2005, Pages 67-78

  Fakruddin, J M ^a   Laurence, J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GLUCOCORTICOID RECEPTOR; MEMBRANE PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; VPR PROTEIN;

ARTICLE; CELL LINE; CHEMISTRY; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; METABOLISM;

CARRIER PROTEINS; CELL LINE; GENE PRODUCTS, VPR; HIV-1; HUMANS; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, GLUCOCORTICOID;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 12944281565     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-004-0395-7     Document Type: Article

References (36)

1. Ayyavoo V, Mahboubi A, Mahalingham S, Ramalingam R, Kudchodkar S, Williams WV, Green DR, Weiner DB (1997) HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor κB. Nat Med 3: 1117-1123
2. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12: 1260-1268
3. Chikatsu N, Takeuchi Y, Tamura Y, Fukumoto S, Yano K, Tsuda E, Ogata E, Fujita T (2000) Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro. Biochem Biophys Res Commun 267: 632-637
4. Crombie R, Silverstein RL, MacLow C, Pearce SF, Nachman RL, Laurence J (1998) Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in saliva. J Exp Med 187: 25-35
5. Collin-Osdoby P, Rothe L, Anderson F, Nelson M, Maloney W, Osdoby P (2001) Receptor activator of NF-κB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem 276: 20639-20672
6. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67: 277-287
7. Fakruddin JM, Laurence J (2004) Interactions among human immunodeficiency virus (HIV-1), interferon-γ, and receptor of activated NF-κB ligand (RANKL): implications for HIV pathogenesis. Clin Exp Immunol 137: 538-545
8. Fakruddin JM, Laurence J (2003) HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor κB ligand (RANKL) secretion and its modulation by HIV protease inhibitors through interferon-γ/RANKL cross-talk. J Biol Chem 278: 48251-48258
9. Fakruddin JM, Laurence J (2004) Regulation of RANKL expression in HIV infection and its therapy: relationship to HIV-linked osteopenia. XV International AIDS Conference, Bangkok, Thailand, Abst WePpB2063
10. Gibbs JS, Regier DA, Desrosiers RC (1994) Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes. AIDS Res Human Retrov 10: 343-350
11. Goh WC, Rogel ME, Kinsey CM, Michael SP, Fultz PN, Nowak MA, Hahn BH, Emerman M (1998) Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med 4: 65-71
12. Goh WC, Manel N, Emerman M (2004) The human immunodeficiency virus Vpr protein binds Cdc25C: implications for G2 arrest. Virology 318: 337-349
13. Heininger NK, Bukinsky MI, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, Gendelman HE, Ratner L, Stevenson M, Emerman M (1994) The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 91: 7311-7315
14. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S (1999) Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140: 4382-4389
15. Kino T, Gragerov A, Kopp JB, Stauber RH, Pavlakis GN, Chrousos GP (1999) The HIV-1 virion-associated protein Vpr is a coactivator of the human glucocorticoid receptor. J Exp Med 189: 51-61
16. Kino T, Gragerov A, Slobodskaya O, Tsapanomichalou M, Chrousos GP, Pavlakis GN (2002) Human immunodeficiency virus type-1 (HIV-I) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators. J Virol 76: 9724-9734
17. Kino T, De Martino MU, Charmandari E, Mirani M, Chrousos GP (2003) Tissue glucocorticoid resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol 85: 457-467
18. Kitazawa R, Kitazawa S, Maeda S (1999) Promoter structurte of mouse RANKL/ TRANCE/OPGL/ODF gene. Biochim Biophys Acta 1445: 134-141
19. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304-309
20. Kong YY, Boyle WJ, Penninger JM (1999) Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. Immunol Cell Biol 77: 188-193
21. Knobel H, Guelar A, Vallecillo G, Nogues X, Diez A (2001) Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS 15: 807-808
22. Lahti AL, Manninen A, Saksela K (2003) Regulation of T cell activation by HIV-1 accessory proteins: Vpr acts via distinct mechanisms to cooperate with Nef in NFAT-directed gene expression and to promote transactivation by CREB. Virology 310: 190-196
23. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106: 1481-1488
24. Levy DN, Refaeli Y, MacGregor RR, Weiner DB (1994) Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 91: 10873-10877
25. Lum JJ, Cohen OJ, Nie Z, Weaver JG, Gomez TS, Yao X-J, Lynch D, Pilon AA, Hawley N, Kim JE, Chen Z, Montpetit M, Sanchez-Dardon J, Cohen EA, Badley AD (2003) Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest 111: 1547-1554
26. Mirani M, Elenkov I, Volpi S, Hiroi N, Chrousos GP, Kino T (2002) HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. J Immunol 169: 6361-6368
27. Mitra D, Sikder SK, Laurence J (1995) Role of glucocorticoid receptor binding sites in the HIV-1 long terminal repeat in steroid-mediated suppression of HIV gene expression. Virology 214: 512-521
28. Mora S, Zamproni I, Beccio S, Bianchi R, Giacomet V, Vigano A (2004) Longitudinal changes of bone mineral density and metabolism in antiretroviral-treated human immunodeficiency virus-infected children. J Clin Endocrinol Metab 89: 24-28
29. Muthumani K, Choo AY, Hwang DS, Chattergoon MA, Dayes NN, Zhang D, Lee MD, Duvvuri U, Weiner DB (2003) Mechanism of HIV-1 viral protein R-induced apoptosis. Biochem Biophys Res Commun 304: 583-592
30. Nagai M, Kyakumoto S, Sato N (2000) Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation. Biochem Biophys Res Commun 269: 532-536
31. Nakamura T, Suzuki H, Okamoto T, Kotani S, Atsuji Y, Tanaka T, Ito Y (2002) Recombinant Vpr (rVpr) causes augmentation of HIV-1 p24 Ag levels in U1 cells through its ability to induce the secretion of TNF. Virus Res 90: 263-268
32. Sawaya BE, Khalilil K, Gordon J, Taube R, Amini S (2000) Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome. J Biol Chem 275: 35209-35214
33. 2 cell cycle arrest. J Virol 74: 8159-8165
34. Theill LE, Boyle WJ, Penninger JM (2002) RANK-L and RANK: T cell, bone loss, and mammalian evolution. Annu Rev Immunol 20: 795-823
35. Thomas J, Doherty SM (2003) HIV infection-a risk factor for osteoporosis. J Acquired Immune Def Syndr 33: 281-291
36. Thirunavukkarasu K, Halladay DL, Miles RR, Yang X, Galvin RJS, Chandrasekhart S, Martin JT, Onyia JE (2000) The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. J Biol Chem 275: 26163-26172